Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Suramin is a trypanocide used in the treatment of African trypanosomiasis (sleeping sickness) and as an anthelmintic in the treatment of onchocerciasis. Intravenous administration.
At the date of the last update we found no published data on its excretion in breast milk.
Its high molecular weight and high binding to plasma proteins make its passage into breast milk improbable, but its very long half-life would facilitate it.
Its low oral bioavailability makes it difficult to pass into the infant's plasma from ingested breast milk, except in premature infants and in the immediate neonatal period when intestinal permeability may be higher.
The precarious clinical situation of affected mothers, which may prevent them from breastfeeding, must be taken into account.